000			02120 a2200553 4500
005			20250512202118.0
264		0	_c19840413
008			198404s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.1983.1.2.91 _2doi
040			_aNLM _beng _cNLM
100	1		_aSkarin, A T
245	0	0	_aImproved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cFeb 1983
300			_a91-8 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aActuarial Analysis
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBleomycin _xadministration & dosage
650	0	4	_aBone Marrow _xdrug effects
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDexamethasone _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLeucovorin _xadministration & dosage
650	0	4	_aLymphoma _xdrug therapy
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xdrug therapy
650	0	4	_aMale
650	0	4	_aMeningeal Neoplasms _xdrug therapy
650	0	4	_aMethotrexate _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aPrognosis
650	0	4	_aVincristine _xadministration & dosage
700	1		_aCanellos, G P
700	1		_aRosenthal, D S
700	1		_aCase, D C
700	1		_aMacIntyre, J M
700	1		_aPinkus, G S
700	1		_aMoloney, W C
700	1		_aFrei, E
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 1 _gno. 2 _gp. 91-8
856	4	0	_uhttps://doi.org/10.1200/JCO.1983.1.2.91 _zAvailable from publisher's website
999			_c6199515 _d6199515